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Fear of cancer recurrence (FCR) is a significant issue for most cancer survivors, which 
is now extensively confirmed by the scientific literature in the psycho-oncology field. 
We aimed to further explore the experience of having FCR from the point of view of 
patients by systematically reviewing qualitative studies. Following PRISMA guidelines, 
64 qualitative studies were selected. All participants’ quotes about FRC were identified, 
then analysed using a conceptual framework based on the emotion-focused therapy 
theory of emotion schemes, which consist of experienced/implicit emotions, along with 
perceptual-situational, bodily-expressive, symbolic-conceptual and motivational-
behavioral elements.  FCR was found to be an intense, difficult, multi-dimensional 
experience. According to participant descriptions, FCR resembles a trauma-like 
phenomenon, including forms of re-experiencing, avoidance, negative thoughts and 
feelings, and arousal or reactivity related to cancer-related triggers or memories. Vivid 
metaphors expressing vulnerability and conflict also reflect the strong impact of FCR in 




• Qualitative data complement and can expand our current knowledge about fear 
of cancer recurrence. 
• FCR is described qualitatively by patients as a complex experience involving 
emotional, perceptual, conceptual, bodily and behavioral dimensions. 
• FCR is a post trauma-like phenomenon: it is an intense and extensive 
experience; it has a flashback-like quality in which painful episodic memories 
related to cancer return repeatedly; it is described through vivid metaphors of 
conflict and vulnerability that emphasize fragility and helplessness. 
• Humanistic-experiential therapeutic approaches might be considered for treating 
maladaptive FCR, which needs further investigation. 
 




Fear of cancer recurrence:  
A systematic review and meta-synthesis of patients’ experiences 
 
1. Introduction 
Metaphorically identified as the Sword of Damocles, fear of cancer recurrence 
(FCR) is defined as the “fear, worry, or concern relating to the possibility that cancer 
will come back or progress” (Lebel et al., 2016, p.3266).  It has been found to some 
degree in 73% of cancer survivors  (Simard et al., 2013).  To a certain extent, this fear is 
an appropriate and normal response to the real threat of cancer and cancer treatments 
(Herschbach & Dinkel, 2014). However, when certain features are present, such as 
recurrent and long-lasting images or thoughts about cancer or death it often proves 
difficult to control and causes significant distress (Mutsaers et al., 2016).  Thus, fear of 
recurrence can become dysfunctional, affecting people’s well-being, quality of life, and 
emotional and social functioning (Cancer Australia, 2011; Herschbach & Dinkel, 2014) 
and in many cases needing clinical attention.  
Due to its relevance and clinical implications for cancer patients, there is 
growing research on FCR and by now there are already several systematic reviews of 
quantitative data about FCR, including prevalence, course over time, determinants and 
consequences (Crist & Grunfeld, 2013; Simard et al., 2013).  In addition, there have 
been reviews of theory (Fardell et al., 2016; Simonelli, Siegel, & Duffy, 2016), 
assessment (Thewes et al., 2012), and intervention (Sharpe, Thewes, & Butow, 2017). 
Drawing on these reviews, it can be said that FCR is a major concern for many people 
with cancer, tends to be stable over time, is more associated with being younger and 
having more (and more severe) physical symptoms, and can impact negatively in 
psychological, functional and quality of life domains (Simard et al., 2013). In terms of 
theoretical orientations, the cognitive-behavioral paradigm is the most common 
formulation for understanding and developing interventions to help people dealing with 
FCR (Fardell et al., 2016). 
Although there is a predominance of quantitative studies, qualitative research 
about FCR has also been conducted, aiming to explore people’s experiences of the 
possibility of recurrence, including the specific contents of their worst fears, their 
coping strategies for dealing with FCR, or what might distinguish higher from lower 
levels of FCR (e.g. Mutsaers et al., 2016; Thewes, Lebel, Seguin Leclair, & Butow, 
2016; Vickberg, 2001). Seeking to understand how people see things (Taylor, Bogdan, 
& DeVault, 2016)  qualitative research is an interpretive, naturalistic approach to 
peoples’ world (Denzin & Lincoln, 2017) that gives voice to participants’ own 
experiences. Qualitative information seems thus particularly important for thorough 
understanding of the phenomenon of FCR and fundamental for informing 
psychotherapeutic practices. Recognized as essential for assessing and improving the 
quality of health care services (NICE, 2012b),  patient’s view brings alive the patient-
centered model of care (Mead & Bower, 2000) where the patient is an active and 
autonomous agent who participates in decision-making processes about their illness and 
its management (Kaba & Sooriakumaran, 2007; Longtin et al., 2010). The patients’ 
expressed feelings, concerns, and experiences during an illness also facilitate a deep 
understanding of how it affects the person as a whole human being (physical, emotional, 
social, spiritual) (Hall, Kunz, Davis, Dawson, & Powers, 2015).  
When we began this review, we couldn’t find any comprehensive 
systematization or synthesis of qualitative data on FCR that could contribute to current 
discussions and developments about it.  Guided by the main research question, “What is 
fear of cancer recurrence for people who experience it?” our aim was to review, 
interpret and synthesize the existing qualitative data about the FCR experience.  
   
2. Method 
2.1. The researchers 
Our research team was composed of two clinical psychologists who have 
worked in a cancer hospital for about 13 years (SNA and ERS) and two university 
professors, one mainly a researcher (CS) and the other a clinical practitioner, researcher 
and teacher (RE). Three of the researchers are Emotion-Focused Therapy (EFT) 
therapists (including one of the developers of EFT) and one (CS) is a family therapist. 
 
2.2. Search strategy  
A systematic search was conducted in April 2016 using the electronic databases 
PsycInfo, PubMED and CINAHL in order to find qualitative research on FCR. The 
search key-terms were “fear/anxiety/worry” combined with “recur*/relapse/coming 
back/progress*” and “cancer/neoplasm”. Additional searches were done through grey 
literature, “snowballing”, journal hand-searches, review-level material (NICE, 2012a) 
and “berrypicking” strategies (Bates, 1989), in order to find additional relevant studies. 
We did not limit our search temporally, and maintained a Google Scholar search alert 
until end September 2016.  
 
2.3. Selection strategy 
The selection of studies was guided by the following inclusion criteria: 1) 
qualitative and mixed method studies about FCR or about wider topics containing this 
particular issue (such as “survivors’ experience”); 2) concerning adult cancer patients; 
3) presented in scientific articles or dissertations; and 4) written in English, French, 
Portuguese or Spanish. We used a broad definition of cancer survivor, considering the 
person from the time of diagnosis until the end of life (NCI, n.d.). Accordingly, we did 
not distinguish “survivor” and “patient” terms and will use both interchangeably 
throughout. 
Figure 1 presents the PRISMA diagram showing the steps followed from the 
initial identification of the studies to the 64 final studies. Each step was completed by 
two of the researchers (SA and ES); the other members of the team participated in the 
decisions related to the final phases of eligibility and inclusion. Covidence, a Cochrane 
software tool for systematic reviews (www.covidence.org) was used to assist the review 
steps since the importation of citations after the databases searches to the selection of 
the studies to be included in the final analysis.  
This review was registered at PROSPERO International prospective register of 
systematic reviews in April 2016 (PROSPERO 2016:CRD42016036688 Available from 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016036688). 
 
2.4. Quality appraisal  
When developing a qualitative meta-analysis, the quality appraisal of the studies 
informs the choice of the studies for the meta-synthesis, helping to make inferences, 
analyze and take conclusions from the data retrieved (Timulak, 2009). In the present 
review, the quality appraisal of the studies was done using a Quality Appraisal Form, 
adapted from the Publishability guidelines for qualitative research, developed by 
Elliott, Fischer, & Rennie (1999). Fourteen criteria were included, from which seven are 
considered pertinent to both qualitative and quantitative approaches and the other seven 
especially pertinent to qualitative research (Elliott et al., 1999). Every criterion was 
assessed as “appropriate”, “inappropriate/insufficient” or “not reported”.  Each study 
was classified as having “high quality” (++), when all or most criteria were rated as 
appropriate or where even if insufficient, the conclusions were very unlikely to change; 
as “moderate/sufficient quality” (+) when some of criteria were rated as appropriate or 
where insufficient or not reported, the conclusions were very unlikely to change; or as 
“low/insufficient quality” (–) when few or no criteria have been fulfilled or the 
conclusions were likely or very likely to change due to the criterion not being met 
(NICE, 2012a). Only the studies rated as “high” or “moderate/sufficient” quality were 
included in the analysis. The studies’ evaluation was done by one judge who rated the 
totality of the studies (SNA) and a second judge who provided a credibility check rating 
half of the studies (ERS). The interrater reliability for the quality judgements was of 
ƙ=0.848, which is considered a strong agreement (McHugh, 2012). None of the 64 
studies selected proved to have “low/insufficient quality”; thus all were included in next 
phases.  
 
2.5. The selected studies 
Sixty-four (64) studies were included in the qualitative synthesis, mostly 
qualitative studies (94%) presented in articles (84%; 16% dissertations). The main 
methods used for data collection were individual interviews (72%), frequently semi-
structured and in-depth, and focus group interviews (17%). Together, the studies 
included a total of 1727 participants, with a range between 1 author reflecting upon his 
personal experience (Horlick-Jones, 2011), and 360 cancer patients who answered an 
on-line open question about their worries (Cesario, Nelson, Broxson, & Cesario, 2010). 
In more than half of the studies (53%), the participants had had breast cancer; another 
25% of the studies included mixed cancer diagnosis. Although different continents – 
Europe, North and South America, Asia and Australia – and different countries were 
represented, about 40% of the studies were originally from the United States of 
America. Years of publication ranged from 1992 to 2016, with more than half of the 
studies having been published between 2010 and 2016. Table 1 presents more detailed 
characterization of the selected studies. 
Concerning the quality of the studies, the majority (about 84%) was considered 
as having “high quality”. The criteria “owning one’s perspective” (criterion 8), 
“providing credibility checks” (criterion 11) and “accomplishing general versus specific 
research tasks” (criterion 13) were the most critical aspects contributing for the lower 
assessments. In line with our leading interest of capturing patients’ experiences on FCR, 
we decided to use for analysis exclusively the quotes from participants, as every 
selected study met the criterion “grounding in examples” of the Quality Appraisal Form 
(criterion 10). 
 
2.6. Data analysis 
Considering the diversity of the selected studies regarding FCR, initially the 
research team roughly divided two sets of studies: 1) studies in which FCR was a 
primary focus or one major result and was extensively discussed (n = 8), and 2) studies 
in which FCR was one of the topics or emerging themes, but not a main or exclusive 
issue of the study (n = 56). The analysis began with the first set of studies, from which 
the first themes were derived. Secondly, the information of the second group of studies 
was fit in the categories already defined, which were checked and adjusted whenever 
necessary.   
Having previously determined to do a grounded theory analysis (Strauss & 
Corbin, 2008) in order to produce the meta-synthesis, the team adopted the Emotion 
Scheme framework (ES; Greenberg, Rice, & Elliott, 1993) to organize the data, 
considering its apparent suitability and in consonance with the research team’s 
assumption that FCR is mainly an emotional experience (Almeida, Silva, Sales, & 
Elliott, 2016).  
An Emotion Scheme is a complex self-organizing process that involves different 
domains of experience – perceptual-situational, bodily-expressive, symbolic-conceptual, 
motivational-behavioural – organized around a particular experienced or implicit 
emotion (Elliott, Watson, Goldman, & Greenberg, 2004). According to EFT theory, 
emotion schemes are the primary implicit source of experience, producing automatically 
felt experiences and action tendencies (Greenberg & Watson, 2006). The elements of an 
ES discriminate complementary and interconnected information about a particular 
emotional experience, enabling us to separate out how people perceive, feel, embody, 
make sense of and act about FCR. We found this underlying framework to be a useful 
yet not overly constraining structure to support our grounded theory analysis (Strauss & 
Corbin, 2008). In addition to being a specific theoretical feature of EFT theory, the ES 
framework comprises common aspects from most psychological theories, such as 
cognitive, emotional, bodily, narrative and behavioural aspects of human experience; 
thus it proved helpful not only to deep knowledge about FCR experience but also to 
inform psychotherapeutic practice.  
 After repeatedly reading the data, the extracted material was analyzed “line-by-
line” (Strauss & Corbin, 2008), and different meaning units were identified, ranging 
from single words to complete sentences or paragraphs, which could be attributed to a 
specific ES domain (experienced/implicit emotion; perceptual-situational, bodily-
expressive, symbolic-conceptual and motivational-behavioral). Then, within each ES 
domain, the quotes of the participants were progressively grouped according to same or 
similar meaning, creating different categories and later higher and lower-order 
categories. At the end of the categorization process, it was possible to find some unique 
meaning units that couldn’t be grouped with any others and which were therefore 
excluded from the final analysis and later synthesis. This process was done by the first 
author and then carefully audited, discussed and revised step by step with one of the 
other researchers (RE), a specialist in both EFT theory and grounded theory analysis.  
  
3. Results 
 In relation to our research question, What is fear of cancer recurrence for people 
who experience it, we found it helpful to further differentiate some of the emotion 
scheme elements into subdomains (see Figure 2): 1) different expressed or implicit 
emotions; 2) trigger–situations that elicited FCR; objects of fear; narrative elements 
related to when, how long and how FCR emerges and related episodic memories (ES 
perceptual-situational domain); 3) bodily expressions of the different emotions (ES 
bodily-expressive domain); 4) metaphors of FCR, distinct dimensions of mental 
activities and cognitions and meta-cognitions about FCR (ES symbolic-conceptual 
domain) and 5) action tendencies related to FCR (ES motivational-behavioural domain). 
We next present each of these themes, using illustrative quotes from participants. 
 
3.1. Emotions associated to the experience of fearing cancer recurrence  
The dominant emotion of the experience of FCR was, as expected, fear. 
Participants described fear by several different terms, using the word “fear” itself (or 
“being afraid”) or synonyms such as “anxiety”, “worry”, “scared”, or “dread”. In 
reading the excerpts, we noticed that the fear was mostly defined by expressions of 
great intensity: “pretty strong fear”, “horrible fear”, “real frightened”, “big dread”, 
“scared the hell out of me”, “very worried”, “terrified”, “panic”, which were much more 
common than “apprehensive” or simply “nervous”. We also included in the emotion of 
fear the feelings of insecurity, uncontrollability and uncertainty reported by some 
participants: “had no sense of security” (Fang & Lee, 2016); “I feel very exposed” 
(Brooks, Poudrier, & Thomas, 2014); “I don’t have control over it”, “always walking 
with uncertainty” (Berman, 2013). Blended fearful states were also detected, 
particularly fear and surprise, as expressed by “fright”, and fear and disgust, as 
expressed by “horror”. 
 Another set of accompanying emotions was labelled as depression, in which we 
included feelings of “sadness”, “loss”, “grief”, “alone” and feeling “set apart” or 
“abandoned” but also descriptions of feeling “more vulnerable”, “weaker” as well as 
being “helpless” and with “no hope” or having “no power about it”. 
General distress or undifferentiated states were other emotions found, probably 
connecting either to fear, sadness or more confusing or unclear states: “extremely 
stressful”, “distressing”, “painful”, “hard”, “very difficult”, “dramatic”, “devastating”, 
“so many feelings”, “freaked out”, “messed up”.   
Positive or pleasant emotions appeared as well in participants’ reports about 
FCR, namely when talking about getting out a fearful state. Participants described being 
“relieved”, getting “more confidence”, feeling “reassured” or comforted after good 
news: “Well, the test showed nothing. There was nothing there, which was very 
comforting....” (Berman, 2013). Feelings of gratitude were also described when 
referring to past or present cancer experiences: “I was lucky this time” (Vickberg, 
2001); “I am thankful that I have a next day” (Cesario et al., 2010). Acceptance was 
another emotional state referred as opposed to fear: “I’ve gotten some peace of mind, 
too, from the acceptance. I don’t have the same level of anxiety” (Berman, 2013).  
The emotions of anger, shame/guilt and surprise were also referred by some 
participants: “I am just angry at my body, it let me down.” (De Vries, Den Oudsten, 
Jacobs, & Roukema, 2014); “I am working way too much and what if I had a 
recurrence? I should be spending this weekend with [my children]. And then that just 
kind of unfolds because you feel guilty and you start thinking about death.” (Berman, 
2013); “It preoccupies me a lot and that surprises me.” (Mikkelsen, Søndergaard, 
Jensen, & Olesen, 2008). 
 
3.2. Trigger–situations that elicit fear of cancer recurrence 
 Noticing something in the body was one of the most referred-to triggers for 
FCR, whether it was a pain or other physical symptom: “Every little pain or lump on 
your body” (Jones, 2012) or a difference in the body related to cancer experience: “your 
breasts just don’t feel the same because the way they construct it with the muscle or 
insert, you can feel all that. They just don’t feel like natural breasts. It’s just another 
trigger” (Berman, 2013). Waiting for a medical exam or appointment (even in the 
waiting room), particularly to receive the results of medical tests, was another common 
identified situation: “But when I really start to think about it is when I have to do scans” 
(Jones, 2012); “Just sitting in that room [waiting for the check-up]” (Raymer, 1993). 
Encountering reminders such as hearing, talking or reading about cancer (in 
TV/newspaper/magazine or by other people), just thinking about it or remembering the 
experience of having had cancer or treatment were also identified triggers of FCR: 
“when I see people in my village dying because of these diseases even years after 
treatment” (Saraf, Singh, & Khurana, 2013); “God, it makes me scared just thinking 
about it now” (Scott, 2014).  
Other situations people described as activating FCR were both being in some 
kind of treatment (such as daily hormone therapy or taking pills for pain) and being off 
treatment (“not having that ‘safety net’ of treatment”, Arnold, 1999).  Finally, being 
under stress or engaging in risky behaviours was a trigger for some: “They say that 
stress is a trigger for getting cancer. So, it’s like every stress has extra stress with it” 
(Berman, 2013); “I haven't been eating properly, and I have been smoking and shouldn't 
be smoking at all...” (Raymer, 1993). 
 
3.3. Objects of fear 
It was possible identify different objects of fear, when people referred to FCR. 
The reoccurrence of the same cancer or of a different one (and even of a different 
serious illness), the spreading of cancer and the fear of the cancer “still being there” 
were directly expressed by participants, as well as fear of cancer itself. Death as a main 
concern was also identified, frequently associated with not wanting to leave family, 
especially children: “I don’t survive it and die, and then my kids are left without a 
mother” (Siegel, Gorey, & Gluhoski, 1997).  Other fears related to doing treatments 
again, feeling weak, suffering or having a diminished quality of life, including being 
dependent and having physical limitations: “It worries me that if comes back, it’s going 
to be stronger” (Berman, 2013); “I think the worst for me was if they find the cancer 
again, would I have to go through the chemotherapy treatments again?” (Raymer, 
1993). Fear of the future, of planning ahead, and more generally fear of uncertainty, 
were described as well. Some patients referred likewise to worry about the worry itself: 
“Sometimes I worry that the worry is going to grow” (Berman, 2013).  
 
3.4. Narrative elements related to when, how long and how FCR emerges 
 Narrative elements were often observed in participants’ discourse, although this 
information was quite heterogeneous across studies and participants. It is possible to 
describe it though in terms of continuums of frequency and of time–duration of the 
experience of FCR, as follows. The presence of FCR ranged from “always present”, 
“every day”, “constant” to “occasionally” or “intermittent”. For some patients, it was 
only present on specific occasions (as reported above in Trigger–situations), or at 
specific moments of the day, frequently at night, especially during quiet times, while 
trying to relax or sleep, and in the morning, when waking up. Others described it as 
appearing “suddenly” or “out of the blue”: 
• “Sometimes I’ll think more about that, but sometimes it’s just ‘that’” (Berman, 
2013). 
•  “There are times still when I wake up (…) before I am completely wide awake 
and I don’t want to get up.” (Raymer, 1993) 
• “On the nights that I wake up, or I can’t get back to sleep” (Flynn et al., 2010).  
We can also locate the emergence of FCR along a chronological line, in relation 
to the cancer diagnosis event. Although for some people this fear has been presented 
“since ever”, even before diagnosis, for most, FCR emerged at the point of the cancer 
discovery, after the treatment ended, or around 5-year mark (for some others it was 
associated to a certain event, as someone’s death from cancer): “From the moment I was 
told I had cancer in my body” (Crouch & McKenzie, 2000). 
Regarding its duration, FCR appears to be episodic, and can be present “for 10 
seconds there” (Berman, 2013) to “a good part of the day (...) six hours maybe” 
(Mutsaers et al., 2016).  
  
3.5. Episodic memories related to FCR 
Specific episodic memories were evoked when people talked about FCR 
(whether asked directly or not), especially related to the different stages of the illness 
trajectory: around cancer diagnosis, situations during the period of treatment, check-ups 
situations, and episodes after the cancer experience: 
• “They say you never forget the day you find your lump and it is true. It was last 
year...and it was Mother’s Day (...) I said I bet it is malignant.” (Raymer, 1993); 
• “It was a hard go at first. The morning I went into the hospital, my husband was 
there and my daughter and I can remember going into the operating room and 
when I came out, they were there.” (Thomas-Maclean, 2001); 
• “I suppose the thing that always sticks in my mind was he [doctor] said it was 
incurable, but treatable” (Kelly & Dowling, 2011). 
Remembrances of past situations previous to cancer diagnosis were also 
reported, including childhood memories such as the first recognition of mortality: “I 
remember the first time I thought ‘someday I am going to die’ and it scared me and I sat 
up in bed and I remember just yelling for my mom” (Sadler-Gerhardt, 2007). Other 
remembered situations concerned or included others, such as conversations with 
doctors/nurses, others’ reactions to his/her illness or relatives/friends/others having 
and/or dying with cancer.  
   
3.6. Bodily expressions of fear of cancer recurrence experience 
 In this category, we identified primarily expressions of fear and expressions of 
depression. Examples of bodily expressions of fear are “shiver” (Raymer, 1993), 
“shaking” (Berman, 2013), “get tense” (Saraf et al., 2013) and “um frio na barriga” 
(literally, “a chill in the belly”; Salci & Marcon, 2010). People also described FCR as 
“nerve-racking” (Thompson et al., 2010), “ficava igual uma corda de violão, bem 
esticada” (It was like a guitar string, stretched tight; Salci & Marcon, 2010), “I am just a 
bunch of nerves (...). And I get pains in other places in my body” (Raymer, 1993), “I 
walk around with nerves on edge” (Grimsbø, Finset, & Ruland, 2011).  
“Crying” was the most presented physical expression of sadness; other examples 
of depression and sadness are “my hearts sinks” (Saraf et al., 2013) and “aquele aperto 
no coração” (tightness in the heart; Salci & Marcon, 2010).  
We also identified general body expressions as “it’s in my bones”; “That feels to 
me like hurt. That feels to me like pain”; “I’d be taking it so far, to the point where I’d 
physically feel sick about the whole thing” (Berman, 2013); “It probably does do weird 
things to your body” (Raymer, 1993). Specific expressions related to head/mind were 
recognized as well: “você fica com a cabeça ‘perturbadinha’” (disturbed head; Salci & 
Marcon, 2010); “I usually feel it in my brain”; “dullness of my thinking” (Berman, 
2013).   
 Physically-expressed laughter was found in different interviews, and we 
considered it as probably expressing different underlying feelings – sometimes was 
expressed when people were talking about worry, seeming to be a nervous laughter; 
other times it looked more related to underlying anger (as when someone described 
feeling annoyed for having been, has one participant said, “false-advertised” in relation 
to the end of treatment). 
 
3.7. Fear of cancer recurrence metaphors 
Sets of metaphors were diverse but we grouped as much as possible under 
similar ideas or meanings. We found a root metaphor (Elliott, 2006) about FCR that we 
called Risk and Danger, under which we distinguished the following different sub-
themes, for which we provide some examples: 
• Being in a war: “I feel under attack again” (Horlick-Jones, 2011); “like a sword 
hanging over my head” (McLoone et al., 2012); “feeling like maybe a bomb is 
going to go off anytime inside our body” (Kvale, Meneses, Demark-
Wahnefried, Bakitas, & Ritchie, 2015); 
• Adversarial situations: “It is like the bad guy and the good guy. I would say, 
yeah you are out there, but let's you know ... let's have a fencing match, you 
know, let's get out the duelling pistols ... so I would be willing to put up a 
battle...” (Raymer, 1993); 
• Guarding Against Attack: “I feel like if I am caught off guard it will sneak round 
the edges … I’m always waiting for it to come back” (Balmer, Griffiths, & 
Dunn, 2015); “Now I feel like the rest of my life is spent fighting and looking 
over my shoulder” (Miller, 2015); 
• Being Attacked by Monsters: “It basically means just a deep-seated kind of 
boogie monster that could resurface again”; “like a little ghost that hunts you” 
(Berman, 2013).  
This first set of metaphors can be grouped together as FCR Is Conflict. 
Another set of metaphors revealed qualities of the experience of FCR, such as 
being a controlling entity, frequently under the surface and that makes people feel 
vulnerable/insecure and injured/ill: 
• A Controlling Entity: “it (FCR) absolutely controlled my life. Totally. Totally 
overshadowed it and totally controlled my life” (Scott, 2014); 
• Under the surface: “But it’s lurking, it’s like anything really that’s troubled you 
for a long time, hidden away in the back there, somewhere, it’ll pop up every 
now and again” (Scott, 2014); “it’s like an undercurrent in your life” (McLoone 
et al., 2012); 
• Vulnerability/Insecurity: “Until something's happened, we all operate under this 
false sense of security. But once something has happened, like this, it's kind of 
like, the bubble's been burst. We realize that something could happen, because it 
has” (Cohen & Ley, 2000);   
• Injury/Illness: “It can become almost crippling if you let it”; “The worry 
undermines that things will always work out” (Berman, 2013). 
This second set of metaphors can be grouped together as FCR Is Vulnerability. 
 
3.8. Dimensions of mental activities: the degrees of certainty, the verbal tenses and 
the sensorial pathways 
The most common and general mental activity identified was thinking, either 
presented as an active reflective process: “When I think of recurrence, I really think of 
dying” [emphasis added] (Berman, 2013); or as a passive process, indicated by 
sentences as “the first thing that comes to my mind is cancer” or “because it brings the 
fear running in my head” [emphasis added] (Berman, 2013).  
Exploring the other mental activities described by participants, we could identify 
different layers or axes that can be related to each other, which we named as: degrees of 
certainty; verbal tenses/time line and sensorial pathways (see Figure 3). Knowing and 
not knowing seemed particularly relevant in participants’ discourses, revealing the poles 
of the continuum degrees of certainty, which included other mental activities such as 
supposing, wondering or believing: “You don’t know if you’re gonna live through it or 
not” (Mutsaers et al., 2016); “Now I guess I know it’s something that can betray you 
without you even knowing what's going on” (Thomas-Maclean, 2001) . We also 
identified mental activities reflecting change processes derived from FCR, such as 
realizing, making sense, understanding, being aware or acknowledging: “This made me 
realize that I will die—not maybe—but I will die!” (Berman, 2013). 
Crossing this axis with the verbal tenses/time line, we realize how different 
mental activities may connect with past (as remembering), present (as in noticing) or 
future (as in expecting).  We’ve also noticed a preponderance of subjunctive 
grammatical modes and interrogative forms, probably reflecting the uncertainty and 
doubts evoked by the fear of cancer recurring, but interestingly for some participants the 
cancer recurrence was assumed as inevitable and in these cases, present and future 
tenses were used: 
• “Oh what if she finds it, it’s just going to change everything…I’d have to stop 
work again. I’d have to rearrange finances” (Jones, 2012); 
• “Will the next test bring me to more treatment? The length of time I have left to 
live, will treatment keep me from working? How will I have health insurance if I 
don’t work? Will my illness leave my husband in debt? What will dying be like? 
Will we have to move from our remote mountain town home? Will I be able to 
leave my husband with enough money to survive?” (Cesario et al., 2010); 
•  “My question is not if it’s coming back...It’s when” (Allen, Savadatti, & Levy, 
2009). 
Different sensorial pathways could also be intersected with the other two axes: 
verbal and auditory sensory channels seemed to relate to “if” statements and 
questioning, as well as with conditional verbal tense; somatic (as in feeling) usually 
reflects present statements and visual-perceptual channel, depicted in verbs as 
imagining, noticing or remembering, seems somehow traverse the whole time line: “I 
almost feel as if it’s inevitable” (Mutsaers et al., 2016); “I imagine ... that maybe it 
[recurrence]... it may be the end ... may be the end and ... that this would take you” 
(Raymer, 1993). 
 
3.9. Cognitions and meta-cognitions about FCR 
Regarding what people reflected about FCR, we could find contents related to 
the internal, psychological process of fearing and meta-cognitions about FCR. Two 
different participants explained their internal process as follows:  
• “[There were] two halves ... on the one side of the balance there was the fear of 
enjoying life because of the other side of the balance which was the possibility 
of recurrence ... This is like a step along the way: that I might be able to actively 
enjoy life on that side of the balance. On the other side of the balance is the fear 
of recurrence, and after that — death.” (Raymer, 1993); 
• “I call it fear because it was paralyzing. There was something that was 
paralyzing to me, and I can only think of it as fear because it was this. And I 
don’t know what I was afraid of. Was I afraid of being sick again? I don’t know 
what I was afraid of...maybe it wasn’t fear of recurrence. Maybe I was confident 
that the cancer would come back, but not being at peace with it? Or not being 
accepting of it?” (Berman, 2013) 
Some meta-cognitions about FCR revealed opposite ideas about FCR, such as it 
being “not an irrational fear” versus being “totally irrational” (Berman, 2013) or “it is 
just a fleeting thought” (Shachar Siman-Tov, 2008) versus “I was obsessed with 
recurrence” (Scott, 2014).  
 
3.10. Action tendencies related to FCR 
  Two chief and opposing action tendencies were identified concerning FCR: 
avoiding and approaching, and within each, we could find aspects related to 
illness/treatment/death, to self-experience, and to others.   
Avoiding. Concerning illness/treatment/death avoidance, participants referred not 
wanting to do treatments or live with cancer again and also not wanting to die with 
cancer. Avoiding medical examinations, disregarding bodily changes, believing doctors 
can prevent a recurrence or simply hoping cancer is not coming back were some other 
desires, wishes, intentions and action tendencies identified: 
• “I wouldn’t do the chemo again, I wouldn’t do it again” (Thewes, Lebel, Seguin 
Leclair, & Butow, 2016); 
• “This is not how I want to die” (Berman, 2013); 
•  “I hope that my cancer doesn’t come back so I can retire and so my wife and I 
can travel and see the world” (Jones, 2012). 
Avoidant self-related action tendencies included mainly trying not to think, talk 
or hear about FCR, wanting to put it aside or out, forget it, distract from it and avoid it. 
Wanting to say “it’s over” or get beyond cancer, wanting to keep normalcy but also not 
wanting to make long-term plans were other self-experiences: 
• “Well, I think you just try to put them [anxieties] to one side as much as you 
possibly can. I don’t let it destroy my day, constantly thinking “oh my God, it’s 
going to come back tomorrow”. I don’t think like that, I try to put it out of my 
mind, keep busy, do interesting things, whatever” (Scott, 2014); 
•  “I wish that I just broke a bone and it’s reset and I’m all healed now and I can 
close the door, like desperately I want to close the door, but I feel like I can’t 
because it is not over” (Berman, 2013). 
Keeping FCR to oneself or isolating oneself, not wanting people to feel sorry for 
them and the need to be independent and to not be a burden to the family were other-
related avoidant behaviours or motivations: “I have never said that to anybody” (Sadler-
Gerhardt, 2007); “I didn’t tell them [family] anything about the cancer probability 
because I didn’t want them to be worried” (Mehrabi, Hajian, Simbar, Hoshyari, & 
Zayeri, 2016). 
Approaching. Several participants heard FCR as impelling them to do something in 
order to feel some control over a possible recurrence, particularly self-care through 
changing food habits and exercise, monitoring and paying attention to body signs, or 
preparing somehow for a recurrence: 
• “I’m doing it, because it makes me feel like I have some control and that wards 
off the worry. I guess my whole strategy is that in order not to worry, I do 
something.” (Berman, 2013); 
• “So, I started on this watching what I eat. Not necessarily a diet, just eating 
correctly what I’m supposed to eat, my vegetables, my fruit …” (Kvale et al., 
2015); 
• “Just checking myself over to make sure there is nothing new.” (Taylor, 
Richardson, & Cowley, 2011). 
Fighting or planning to fight against a future cancer recurrence was another 
action tendency described: “I sure as hell would give it [recurrence] a fight, ha ha. I 
would fight, you know ... I would not accept death you know... I wouldn’t just lay back 
and say all right, you know, I am going to die.” (Raymer, 1993); 
Underneath FCR, another need was identified for participants, the need to 
accept, deal or recognize their mortality and ultimately prepare for their own death:  
• “Then you have to learn to ... I guess deal with the question... How can I put it? 
Of then really learning to accept the fact that, you know, to accept death” 
(Raymer, 1993); 
•  “How do I want to leave things? How do I want my family to perceive me?” 
(Berman, 2013). 
Regarding self-experiences, we recognized self-talking, mainly self-coaching 
and self-assurance, the need to deal or live with FCR, but also the wanting to live and 
appreciate life better. We also included in this sub-theme spirituality, expressed by 
having faith and praying. Here are some examples: 
• “I can kind of, you know, calm myself down, this kind of thing.” (Cohen & Ley, 
2000); “Because I just tell myself I’m not going to worry about it. If it happens, 
it happens. Deal with it then.” (Thomas-Maclean, 2001); 
• “And I just want to live my life. I want to live it as fully as I can.” (Shachar 
Siman-Tov, 2008).  
Sharing their experiences with others, talking about FCR and receiving comfort 
and help from others (including in therapy) were other helpful approaching strategies 
people described when dealing with FCR: 
• “When I have a fearful moment I tell my brothers, sisters and partner that I am 
worried.” (De Vries et al., 2014); 
•  “Another cancer survivor telling me ‘it’s okay, don’t worry ’, would be such a 
great comfort and I wouldn’t feel scared anymore.” (Wang et al., 2016) 
We also found combined action tendencies, holding awareness of approaching 
and avoiding at the same time, in the discourse of some participants, as seen in the 
following examples:  
• “Sometimes I just try to ignore it. Sometimes I tell myself it’s already there and 
there’s not much I can do but just to face it...” (Raymer, 1993); 
• “Just by having this kind of attitude, confronting breast cancer and the fear it’s 
evokes, and at the same time letting go, and surrendering kind of approach.” 
(Shachar Siman-Tov, 2008). 
Finally, FCR was described as paralysing or blocking any action tendency: “I 
was just so paralyzed by fear” (Berman, 2013); “it’s just almost crippling” (Mutsaers et 
al., 2016).  
 
4. Discussion 
The purpose of this qualitative meta-synthesis was to bring together what is 
known about the experience of fear of cancer recurrence, using cancer patients’ 
described experiences. Based on our analysis and synthesis, FCR is a complex, intense 
and difficult human experience involving different emotional, perceptual, mental, bodily 
and behavioral aspects. Our findings consolidate some previous knowledge on FCR, 
such as the importance of certain triggers that elicit FCR, specific objects of fear or 
coping strategies, and uncover overlooked aspects related to emotional dimensions, 
including bodily and metaphorical expressions.     
Our sample of studies was quite heterogeneous, in terms of number of 
participants and their characteristics, and data collection methods. Although breast 
cancer was the most represented diagnosis, nearly half of the studies included other 
cancer diagnoses, and some studies explored cancer experiences within a specific 
culture (e.g. USA ethnic groups) or region (e.g. rural Scotland); nevertheless, in all the 
studies participants considered FCR to be an important concern. Interestingly, FCR was 
much represented in studies that were not directly studying it: even if not asked about, 
cancer patients spontaneously referred its presence, importance and impact. This idea is 
highlighted by previous reviews of FCR as a universal experience among cancer 
patients even if to varying degrees (Simard & Savard, 2009). 
In our review it was possible to find rich accounts of each of different 
dimensions of human experience: emotional, perceptual, cognitive, bodily and 
behavioral.  The multidimensionality of FCR has been recognized from the earliest 
theoretical formulations (Lee-Jones, Humphris, Dixon, & Hatcher, 1997; Fardell et al., 
2016), and common aspects of the diverse explanatory theories of FCR include triggers, 
appraisal processes and the role of cognitions and beliefs, as well as behavioral/coping 
responses (Fardell et al., 2016; Simonelli et al., 2016). Apparently, emotional and 
bodily aspects have not been much explored yet. 
Regarding the emotions revealed by the participants of the studies reviewed, fear 
was naturally central to most of peoples’ experiences on FCR, but we could find other 
accompanying emotions as well, such as sadness, anger and very frequently 
undifferentiated negative states. Considered as adaptive emotions, fear relates to a 
situation of danger, sadness to a lived loss or psychological injury and anger to a 
situation of violation or attack on self (Greenberg & Paivio, 1997). All these situations 
can be easily met in the cancer trajectory, particularly by the life-threatening nature of 
cancer, the various losses that the disease often carries and the sense of violation of 
physical and psychological integrity eventually brought by the disease itself or by its 
treatments. Those feelings can however be maladaptative, and if not adequately 
managed and regulated, can compromise successful adjustment to cancer experience 
(Conley, Bishop & Andersen, 2016). Difficulties on emotion regulation can impact 
negatively on psychological and physical well-being (Brandão, 2017; Giese-Davis, 
Conrad, Nouriani, & Spiegel, 2008). Psychotherapy can allow the exploration and 
differentiation of the different emotion states, especially the more undifferentiated ones, 
thus facilitating successful emotional processing (Pascual-Leone & Greenberg, 2007). 
Activators of the FCR experience were most commonly noticing something in 
one’s own body, waiting for medical exams and results, encountering reminders such as 
talking or hearing about cancer, or simply thinking or remembering about cancer 
experience or a potential recurrence. External and internal triggers have actually been 
included in most theoretical approaches already developed for understanding FCR 
phenomenon (Fardell et al., 2016), but their frequency does not necessarily distinguish 
clinical from non-clinical FCR (Mutsaers et al., 2016).  
The studies we have reviewed point to FCR not as a unique/simple fear, but 
rather suggest that it is a set of different fears for different people or even for the same 
person at different times. This finding is in line with the studies of Raymer (1993) and 
Vickberg (2001), in which cancer patients revealed different specific fears while talking 
about FCR (not always or uniquely of death). We can notice furthermore that some 
fears are about something known, such as going through certain treatments again, while 
others are about the unknown, such as the uncertainty of the disease course or death 
itself.  This supports the distinction made between fear and anxiety (Elliott, 2013; 
Steimer, 2002), the former relating to a present or specific danger, the latter to a future 
or undefined danger. Considered as a main fear, the fear of death is, according to 
existential psychotherapy, one of humans’ ultimate concerns and a source of natural 
anxiety, which can be catalyzed by the confrontation with the possibility of one’s own 
death (Yalom, 1980). Death anxiety has been also considered a transdiagnostic 
construct (Iverach, Menzies, & Menzies, 2014). The potential threat of death might 
connect to feelings of fear as well as sadness, as expressed by this participant in 
Berman’s study (2013): “The sadness of thinking that I might not be there is horrifying; 
it really is”. Fears of death, dependence, disfigurement, disruption and disability have 
previously been identified as common in cancer patients (e.g. Lesko, 1998).    
Although there were a multiplicity of experiences regarding when, how and how 
long this experience endures, FCR tended to be described by participants from different 
studies as being always present, or in the back of the mind, and existing since having 
had the cancer diagnosis. Daily recurrent thoughts and duration of 30 minutes or more 
have been identified as possible features of clinical FCR (Mutsaers et al., 2016), but it 
was not possible in our review to distinguish different levels of FCR in participants. 
While describing FCR, certain episodic memories were recalled by participants 
and might act as internal triggers for FCR, possibly stemming from traumatic 
experiences during the illness trajectory. FCR has been associated with post-traumatic 
stress disorder (PTSD) symptoms (Black & White, 2005; Simard et al., 2013). 
According to DSM-V, we can find some criteria of PTSD in patient discourses in our 
review, such as re-experiencing of aspects of traumatic cancer-related events, in the 
form of flashbacks, emotional distress or physical reactivity after exposure to trauma 
reminders; avoidance of trauma-related stimuli; negative thoughts or feelings after the 
trauma; and trauma-related arousal and reactivity, including hypervigilance, heightened 
startle reaction or difficulty sleeping (APA, 2013). This could orient therapists towards 
recognizing and treating traumatic responses, when treating clinical FCR. 
People expressed FCR by different means, either verbally or bodily. Metaphors 
were frequently used as mental representations of the FCR experience, following Lakoff 
& Johnson's (2003) idea that metaphors structure what we think and understand, as well 
as our actions. It can also retain indescribable aspects of extremely difficult experiences 
(Berman, 2013). Our categorization of the metaphors resembles some of the conceptual 
metaphors for fear described by Kövecses (1990), from which we present some possible 
matches: FEAR IS AN OPPONENT IN A STRUGGLE (Kövecses, 1990), parallels our 
categories “adversarial situations” and “being in a war”; FEAR IS A HIDDEN ENEMY 
(Kövecses, 1990) fits our “under the surface”; FEAR IS AN ILLNESS (Kövecses, 
1990) goes with “injury/illness”; FEAR IS A SUPERNATURAL BEING (Kövecses, 
1990) fits “being attacked by monsters”. We also noticed that descriptions or metaphors 
about FCR were inseparable from patient’s views/metaphors about cancer itself: the 
above conceptual metaphors for fear might actually overlap with cancer metaphors – 
cancer as an opponent in a struggle; cancer as a hidden enemy; cancer as an illness; 
cancer as a supernatural being. A meta-synthesis about cancer fears in the general 
population also found a core view of cancer as a vicious, unpredictable and 
indestructible enemy (Vrinten et al., 2017). Metaphors can help symbolize experiences 
in psychotherapy, and even can be used for tracking therapeutic change (Levitt, 
Korman, & Angus, 2000).  
Certain verbs and verb tenses revealed different mental activities related to FCR. 
The common subjunctive grammatical modes can easily recall the uncertainty 
experienced by cancer survivors (e.g. Elmir, Jackson, Beale, & Schmied, 2010; Scott, 
2014) and the role of tolerance of uncertainty (for a review of the concept, see Hillen, 
Gutheil, Strout, Smets, & Han, 2017) as related to FCR (Fardell et al., 2016). Yet, the 
cognitive activity also reflected the embodied mind (Lakoff & Johnson, 1999) and its 
sensory activities, such as when participants used visual or somatic terms (as seeing or 
feeling). Some bodily-expressive elements can be seen simultaneously as direct and 
metaphorical expressions, as when people refer shivering or being paralyzed by fear, 
whilst others are direct bodily expressions, as when people cried during the interviews 
when expressing sadness. Body-oriented therapeutic strategies, as focusing or clearing a 
space, have been used with cancer patients (Katonah & Flaxman, 1991; Lennox & 
Summers, 2010) and could be explored for helping people dealing with FCR.      
Responding to FCR appeared to be a challenging task, and people either showed 
efforts to face the possibility of recurrence and their fear itself or else avoided the 
experience of FCR or its activators; this resembles the engagement versus 
disengagement coping strategies found in other studies (e.g. Conley, Bishop, & 
Andersen, 2016) but also the biological responses of fight or flight before a dangerous 
situation. It was also possible to find conflict or ambivalence between these two 
opposing action tendencies, making it difficult in assess the adaptive value of each of 
these responses, and pointing to an internal motivational conflict over learned 
maladaptive responses to traumatic aspects of the cancer experience. It’s interesting to 
note that in the general population, greater familiarity with cancer has been shown to 
increase fear, while a greater distance diminished it and brought a sense of safety to 
people (Vrinten et al., 2017).  
Although the experts in the field of FCR have suggested maladaptive coping 
(exemplified by avoidance, reassurance seeking and body checking) as a possible 
characteristic of clinical FCR (Lebel et al., 2016), Mutsaers and colleagues (2016) failed 
to find a difference in coping strategies between clinical from non-clinical FCR 
(Mutsaers et al., 2016). As considered generally for the anxiety problems, possibly the 
main issue is how much distress the avoidance process brings the person and how much 
it disturbs his/her life functioning or goals, since the avoidance can affect not only the 
feared situations/triggers but also may involve avoiding the internal painful emotional 
experiences as well (Behar, DiMarco, Hekler, Mohlman, & Staples, 2009; Elliott, 
2013). The fear of emotional pain and its avoidance are recognized by different 
therapeutic approaches as hampering the processing of difficult experiences (Timulak & 
Pascual-Leone, 2014) in psychotherapy.    
Our exploration of the range of different expressions and meanings of FCR for 
cancer patients can bring some more insights for oncology clinical practice in general 
and specifically for psychotherapeutic practice. The different dimensions revealed 
support a wider perspective on the human experience of FCR, reinforcing the 
importance of humanizing health care by considering the person as a whole and 
simultaneously attending to the different dimensions of his/her experience. This can 
inform more effective communication between health care professionals and patients. 
Regarding therapeutic interventions, the cognitive-behavioral paradigm has so far been 
the main framework for approaching FCR (Fardell et al., 2016), but other possible 
lenses of understanding and treating FCR, such as supportive-experiential (Herschbach 
et al., 2010) or supportive therapies (Simonelli et al., 2016), have been also suggested. 
FCR can be seen as a problematic experience that needs to be assimilated (Stiles et al., 
1990) through an emotional deepening process (Pascual-Leone & Greenberg, 2007; 
Timulak & Pascual-Leone, 2014). This can be done first through the differentiation of 
negative emotional states from global to specific, followed by exploration of secondary 
or defensive reactions (e.g., fear of fear) to find the underlying primary emotions, some 
of which are maladaptive (e.g., trauma-based fear or shame) and need to be transformed 
into adaptive emotions with corresponding adaptive actions. From this point of view, 
non-clinical FCR is likely to an adaptive emotional response, related to the real threat of 
a recurrence, leading to adaptive needs and actions of protection and surveillance.  On 
the other hand, a dysfunctional FCR might be initially experienced as an (more or less) 
undifferentiated fear-based emotion or a secondary fear of fear or an avoidant emotional 
numbing.  These might eventually be related to past traumatic events that cause high 
distress when they break through. The Cancer Australia review (2011) on FCR found, 
on one hand, a relationship between FCR and increased screening, prevention behaviors 
and increased contact with the health system and, on the other hand, an association 
between FCR and previous anxiety or PTSD (Cancer Australia, 2011).  The main point 
that we draw, however, is that FCR is highly diverse, requiring that psychotherapy 
proceed from the exploration of specific meanings of FCR for each patient. 
The dimensions examined in this review encourage more research on therapeutic 
approaches in addition to cognitive-behavioral for treating clinical FCR, as more light 
has been brought to aspects less explored so far in the literature on FCR, including 
emotional or bodily features. Taking also into account the theoretical orientation of 
most of our research team, we believe psychotherapies oriented to emotional and 
experiential aspects (as EFT or in general humanistic-experiential therapies), could be 
explored as a possible alternative.   
 Methodological Issues. Our team’s choice of using only participants’ direct 
quotations was congruent with our main goal of trying to know people’s experience on 
FCR using their own “voice” and also with striving to respect the qualitative nature of 
the studies analysed.  Nevertheless, being a secondary analysis, the data of our review 
was a potentially biased collection of published excerpts selected by the original 
authors.   
We consider our selection of studies somehow too diverse, characterized by very 
different objectives and a huge and heterogeneous amount of information, which made 
the analysis more difficult. Notwithstanding, this made it possible to examine the 
presence of FCR in a variety of samples and types of studies, finding similar aspects of 
this experience independent of the goal of the study. Another limitation is the 
impossibility of distinguishing non-clinical from clinical FCR in the selected studies, 
which could be quite important for psychotherapeutic purposes.  
 Organizing our data around the emotion scheme structure can as well be 
questioned as arbitrary, but we consider this as a valid option for analysing the gathered 
information, which allowed us to explore FCR as an emotional experience, reflecting 
simultaneously our theoretical assumptions from a constructivist-interpretivist stance 
(Ponterotto, 2005) and our specific allegiance to Emotion-Focused Therapy. 
Considering the therapeutic utility of this review, we note that the emotion scheme 
elements are nevertheless recognizable as core aspects of the human experience, and 
therefore potentially useful within any psychotherapeutic approach. 
Considering the qualitative nature of this systematic review, we carried out and 
audited our analysis carefully, including following clear criteria for the studies to be 
included in the analysis. (We also followed recent recommendations for qualitative 
research; see Levitt, Motulsky, Wertz, Morrow, & Ponterotto, 2017.) Even taking into 
account the goals of reviewing and synthesizing, we particularly realized the difficulty 
of maintaining the principle of contextualization of data (Levitt, Motulsky, Wertz, 
Morrow, & Ponterotto, 2017). Therefore, the general results we presented might not fit 
exactly specific samples or participants with different ages, different cancer diagnoses, 
cultural backgrounds, or nationalities; instead, we have tentatively approached possible 
common or main features consistent across different samples. 
 
5. Conclusion 
Using direct words from cancer survivors, data obtained for this systematic 
review reinforced FCR as a concern with major impact in people’s lives. Beyond 
aspects such as triggers, cognitions and coping behaviors, more clearly defined in 
previous work, we could also find different emotions related to FCR experience, 
particularly episodic memories evoked by it, bodily expressions, metaphors and distinct 
dimensions of mental activities, not so focused till now in the literature. The nature of 
patients’ descriptions in the different domains points towards trauma-like experiences, 
especially re-experiencing, avoidance and hyperarousal aspects.  
FCR is not an isolated phenomenon in the person's experience, but strongly 
affects all aspects of their experience: perceptions, emotions, bodily experiences, 
cognitions and behavior/motivation, making it a complex human experience. Focusing 
on FCR as an emotional experience that aggregates those different aspects brings a 
novel perspective to this overview of the FCR literature. We believe this perspective can 
positively contribute to it, encompassing and valuing aspects so far not so studied. Thus, 
in helping clients address their fear of cancer recurrence therapists need to work 
holistically and comprehensively with all aspects of the person. In this sense, 
humanistic-experiential psychotherapies can offer a promising approach to clinical 
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Table 1. Characteristics of the selected studies 
Articles 54 (84%) 
Dissertations 10 (16%) 
Studies exclusively qualitative 60 (94%) 
Mixed qualitative/quantitative studies 4 (6%) 
Data Collection method   
Individual interviews 46 (72%) 
Focus group interviews 11 (17%) 
Mixed qualitative methods 3 (5%) 
Other methods  4 (6%) 
Total participants 1727 (range 1 – 360) 
Mean (median) per study 28 (16) 
Standard Deviation 47 
Diagnosis Number of studies (%) 
Breast 34 (53%) 
Mixed diagnosis 16 (25%) 
Gynecological 7 (11%) 
Blood cancers (leukemia, lymphoma, myeloma)  4 (6%) 
Others (colorectal; head and neck and melanoma) 3 (5%) 
Countries  
USA 26 (41%) 
UK 9 (14%) 
Australia 6 (9%) 
Canada 6 (9%) 
Scandinavia (Denmark, Norway, Sweden) 5 (8%) 
Brazil 3 (5%) 
Others 6 (9%) 
Mixed countries 3 (5%) 
Year of publication Number of studies 
1992-1999 7 (11%) 
2000-2009 22 (34%) 
2010-2016 35 (55%) 
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Figure 2. Synthesis of the high-level results according to the emotion scheme framework 
(adapted from Elliott et al, 2004) 
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